Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CENPI - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KLHL36 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GNB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NONO - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
USP28 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FANCI - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RUNDC3B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
JSRP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STAT5B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DDX17 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF561 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IGF1R - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBM25 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PAPOLA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAPGEF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on